Skip to main content

Table 10 Association between lipodystrophy and the metabolic syndrome and its individual components in women

From: Impact of Lipodystrophy on the prevalence and components of metabolic syndrome in HIV-infected patients

 

Modelo 1

OR (95% CI)

Modelo 2

OR (95% CI)

Modelo3

OR (95% CI)

MS ATP III

1.074 (0.501-2.303)

0.763 (0.298-1.952)

2.730 (0.810-9.194)

High waist circumference

0.394 (0.178-0.869)

0.306 (0.118-0.796)

--

Hypertriglyceridemia

4.091 (1.557-10.750)

3.091 (1.063-8.989)

5.917 (1.50-23.349)

Low HDL cholesterol

2.765 (1.174-6.513)

2.308 (0.885-6.020)

3.990 (1.252-12.716)

High fasting glucose

0.713 (0.298-1.701)

0.560 (0.204-1.534)

0.758 (0.240-2.390)

High blood pressure

0.826 (0.371-1.839)

0.511 (0.177-1.474)

0.917 (0.273-3.078)

MS IDF

1.613 (0.742-3.507)

1.461 (0.572-3.736)

5.290 (1.502-18.635)

High waist circumference

0.543 (0.212-1.393)

0.385 (0.127-1.164)

--

Hypertriglyceridemia

4.091 (1.557-10.750)

3.091 (1.063-8.989)

5.917 (1.500-23.349)

Low HDL cholesterol

2.765 (1.174-6.513)

2.308 (0.885-6.020)

3.990 (1.252-12.716)

High fasting glucose

0.713 (0.298-1.701)

0.560 (0.204-1.534)

0.758 (0.240-2.390)

High blood pressure

0.826 (0.371-1.839)

0.511 (0.177-1.474)

0.917 (0.273-3.078)

  1. Model 1 - OR crude
  2. Model 2 - OR adjusted for gender, age and cART
  3. Model 3 - OR adjusted for gender, age, duration of cART and BMI